Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.
about
The Justy mutant mouse strain produces a spontaneous murine model of salivary gland cancer with myoepithelial and basal cell differentiationSalivary acinic cell carcinoma: reappraisal and update.Intratumoral delivery of recombinant vaccinia virus encoding for ErbB2/Neu inhibits the growth of salivary gland carcinoma cellsAfatinib and its encapsulated polymeric micelles inhibits HER2-overexpressed colorectal tumor cell growth in vitro and in vivoHigh-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma.Human Epidermal Growth Factor Receptor 2 (HER2/neu) in Salivary Gland Carcinomas: A Review of Literature.Correlation between apparent diffusion coefficients and HER2 status in gastric cancers: pilot study.Primary Pulmonary Mucoepidermoid Carcinoma: Histopathological and Moleculargenetic Studies of 26 Cases.Molecular genetic studies on EGFR, KRAS, BRAF, ALK, PIK3CA, PDGFRA, and DDR2 in primary pulmonary adenoid cystic carcinoma.Breast metastasis of salivary duct carcinoma in a patient: a case report.Tissue microarray construction for salivary gland tumors study.Salivary mucoepidermoid carcinoma revisited.Impact of postoperative radiotherapy and HER2/new overexpression in salivary duct carcinoma : A monocentric clinicopathologic analysis.A low percentage of HER-2 amplification whereas indicates poor prognosis in salivary carcinoma ex pleomorphic adenoma: a study of 140 cases.Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01).Programmed death ligand-1 expression is associated with poor disease free survival in salivary gland carcinomas.Targeted Approaches Applied to Uncommon Diseases: A Case of Salivary Duct Carcinoma Metastatic to the Brain Treated with the Multikinase Inhibitor Neratinib.Utility of Immunohistochemistry and ETV6 (12p13) Gene Rearrangement in Identifying Secretory Carcinoma of Salivary Gland among Previously Diagnosed Cases of Acinic Cell Carcinoma.Expression of Hormone Receptors and HER-2 in Benign and Malignant Salivary Gland Tumors.Androgen deprivation therapy for androgen receptor-positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands.Significant and durable clinical benefit from trastuzumab in 2 patients with HER2-amplified salivary gland cancer and a review of the literature.Mammary analog secretory carcinoma, low-grade salivary duct carcinoma, and mimickers: a comparative study.Cutaneous adnexal adenocarcinoma with exquisite sensitivity to trastuzumab.Assessment of protein expression and gene status of human epidermal growth factor receptor (HER) family molecules in ameloblastomas.Immunohistochemical and molecular profile of salivary gland cancer in children.Mutation analysis of the EGFR pathway genes, EGFR, RAS, PIK3CA, BRAF, and AKT1, in salivary gland adenoid cystic carcinoma.Polyethylene glycol-conjugated HER2-targeted peptides as a nuclear imaging probe for HER2-overexpressed gastric cancer detection in vivo.
P2860
Q28507071-7C26BF52-1910-4005-A5FC-2253F3EDCFB5Q30252000-60B70048-2E8F-4B0C-B609-274C8E33CC90Q33645792-61847387-545A-4A96-BD11-2F4CC04AE4A1Q34104079-643A774F-3111-4C47-909B-0772D6C8ACCDQ34436470-316AEA9A-55ED-4A59-8B11-5B115266FAFEQ35230643-2ED8CF0B-066F-439B-8930-B9AD636EC234Q35815603-6B2027B9-BC2E-4EA4-A23B-E4CED7F772C3Q35843530-0B509CF7-C7B8-416C-9A8D-AEDA0D65BCDCQ36063032-D82AF1B7-619B-40ED-B7B6-A7F2AE322CB0Q36493317-1E1D64E6-4289-4498-8FF1-36FF8FE764CEQ36544198-83578A13-0B0F-407E-A50F-821C71E85151Q38207529-5213EF73-4ADF-4ADD-9282-C41A5C12DE6FQ38614842-D4D7B355-1309-4AC5-9F6B-4EFB456A9CDEQ38841254-DA61606A-AA3E-4132-81A3-C684DA5EEA68Q39012625-75D1721F-BF3D-49CB-B020-AB7B96B56323Q40783341-9045C3C6-B613-4930-BCBB-16158DFA25FCQ41601105-2983E64D-9618-486D-AC11-3A0D40D44387Q42290998-1607C806-40E8-458F-A62F-15E28531F87FQ45996599-E14E62DC-9DA3-4653-9751-365D47ADE5FDQ47259493-E52C2F1A-5C24-485E-9664-388F39199790Q48123633-5B399660-2767-4C39-BE3A-C801036812A4Q48170512-23BF7B06-7C40-4DC0-8901-A65D84AF0E9DQ51127479-4656D64C-94DC-417C-846F-8E48512212AAQ53126969-1A0EDDDD-A17E-4FED-8123-075000EA065FQ54129929-A8514555-98D7-4F08-8C0E-F7865EBE6CE2Q55004879-CF61BA0A-E632-4E95-A298-2E7B6F89218CQ55286461-B96A3F0B-9408-451A-9BB3-56B8E78F9215
P2860
Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.
@en
type
label
Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.
@en
prefLabel
Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.
@en
P2093
P1433
P1476
Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.
@en
P2093
Adrian Münscher
Alexander Gnoss
Carsten Bokemeyer
Guido Sauter
Linn Gravert
Maren Reiff
Maria-Christina Tsourlakis
Rainald Knecht
Till Sebastian Clauditz
Waldemar Wilczak
P304
P356
10.1097/PAT.0B013E3283484A60
P577
2011-08-01T00:00:00Z